Terms: = Cervical cancer AND EP300, ENSG00000100393, 2033, RP1-85F18_1, p300
54 results:
1. Projected Time for the Elimination of cervical cancer Under Various Intervention Scenarios: Age-Period-Cohort Macrosimulation Study.
Chen YC; Chen YY; Su SY; Jhuang JR; Chiang CJ; Yang YW; Lin LJ; Wu CC; Lee WC
JMIR Public Health Surveill; 2024 Apr; 10():e46360. PubMed ID: 38635315
[TBL] [Abstract] [Full Text] [Related]
2. miR-129-5p inhibits anchorage-independent growth through silencing of ACTN1 and the ELK4/c-FOS axis in HPV-transformed keratinocytes.
Huseinovic A; Xu M; Jaspers A; Bais B; Steenbergen RDM
J Med Virol; 2024 Apr; 96(4):e29580. PubMed ID: 38566572
[TBL] [Abstract] [Full Text] [Related]
3. NDUFA8 is transcriptionally regulated by ep300/H3K27ac and promotes mitochondrial respiration to support proliferation and inhibit apoptosis in cervical cancer.
Xiang H; Tang H; He Q; Sun J; Yang Y; Kong L; Wang Y
Biochem Biophys Res Commun; 2024 Jan; 693():149374. PubMed ID: 38096616
[TBL] [Abstract] [Full Text] [Related]
4. The differences in immune features and genomic profiling between squamous cell carcinoma and adenocarcinoma - A multi-center study in Chinese patients with uterine cervical cancer.
Li J; Xue X; Zhang Y; Ding F; Wu W; Liu C; Xu Y; Chen H; Ou Q; Shao Y; Li X; Wu F; Wu X
Gynecol Oncol; 2023 Aug; 175():133-141. PubMed ID: 37356314
[TBL] [Abstract] [Full Text] [Related]
5. PHLDA1 is a P53 target gene involved in P53-mediated cell apoptosis.
Song X; Zhou L; Yang W; Li X; Ma J; Qi K; Liang R; Li M; Xie L; Su T; Huang D; Liang B
Mol Cell Biochem; 2024 Mar; 479(3):653-664. PubMed ID: 37155089
[TBL] [Abstract] [Full Text] [Related]
6. ROS1 as a possible prognostic biomarker of cervical adenocarcinoma: An exploratory analysis with next-generation sequencing.
Machida H; Matsuo K; Tanaka M; Kitatani K; Takase A; Yokoyama K; Kajiwara H; Yasaka M; Ikeda M; Yoshida H; Hirasawa T; Mikami M
Gynecol Oncol; 2023 Apr; 171():59-66. PubMed ID: 36804622
[TBL] [Abstract] [Full Text] [Related]
7. The PIK3CA-E545K-SIRT4 signaling axis reduces radiosensitivity by promoting glutamine metabolism in cervical cancer.
Jiang W; Ouyang X; Ji Z; Shi W; Wu Y; Yao Q; Wang Y; Yang W; Xiang L; Yang H
Cancer Lett; 2023 Mar; 556():216064. PubMed ID: 36646410
[TBL] [Abstract] [Full Text] [Related]
8. [Determination of Human Papilloma Virus (HPV) Genotype Prevalance and Distrubution in Adana: A Hospital-Based Study Between 2014-2021].
Alışkan HE; Öğüç Şanlı Ö; Aka Bolat F; Alkaş Yağınç D; Toprak U
Mikrobiyol Bul; 2023 Jan; 57(1):119-133. PubMed ID: 36636851
[TBL] [Abstract] [Full Text] [Related]
9. An integrative approach toward identification and analysis of therapeutic targets involved in HPV pathogenesis with a focus on carcinomas.
Gupta AK; Kumar M
Cancer Biomark; 2023; 36(1):31-52. PubMed ID: 36245368
[TBL] [Abstract] [Full Text] [Related]
10. METTL3 potentiates progression of cervical cancer by suppressing ER stress via regulating m6A modification of TXNDC5 mRNA.
Du QY; Huo FC; Du WQ; Sun XL; Jiang X; Zhang LS; Pei DS
Oncogene; 2022 Sep; 41(39):4420-4432. PubMed ID: 35987795
[TBL] [Abstract] [Full Text] [Related]
11. [Correlation analysis of Poor Prognosis and Immunotherapy of lncRNAs Related with m
Gu R; Liu M; Lin P; Feng TY; Yuan H; Ou DQ; Li SQ; Li Q; Zhao G; Zhang J; Li K
Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Jul; 53(4):626-636. PubMed ID: 35871733
[TBL] [Abstract] [Full Text] [Related]
12. Knockdown of MIR9‑3HG inhibits proliferation and promotes apoptosis of cervical cancer cells by miR‑498 via ep300.
Li F; Liang Y; Ying P
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34468010
[TBL] [Abstract] [Full Text] [Related]
13. Stereotactic ablative body radiotherapy boost for cervical cancer when brachytherapy boost is not feasible.
Lee TH; Song C; Kim IA; Kim JS; Kim YB; Kim K; No JH; Suh DH; Chung JB; Eom KY
Radiat Oncol; 2021 Aug; 16(1):148. PubMed ID: 34384450
[TBL] [Abstract] [Full Text] [Related]
14. p300-Catalyzed Lysine Crotonylation Promotes the Proliferation, Invasion, and Migration of HeLa Cells via Heterogeneous Nuclear Ribonucleoprotein A1.
Han X; Xiang X; Yang H; Zhang H; Liang S; Wei J; Yu J
Anal Cell Pathol (Amst); 2020; 2020():5632342. PubMed ID: 33457194
[TBL] [Abstract] [Full Text] [Related]
15.
Gospodinova ZI; Zupkó I; Bózsity N; Manova VI; Georgieva MS; Todinova SJ; Taneva SG; Ocsovszki I; Krasteva ME
Z Naturforsch C J Biosci; 2021 Mar; 76(3-4):129-140. PubMed ID: 32975208
[TBL] [Abstract] [Full Text] [Related]
16. Mutation profiling of uterine cervical cancer patients treated with definitive radiotherapy.
Yoshimoto Y; Sasaki Y; Murata K; Noda SE; Miyasaka Y; Hamamoto J; Furuya M; Hirato J; Suzuki Y; Ohno T; Tokino T; Oike T; Nakano T
Gynecol Oncol; 2020 Nov; 159(2):546-553. PubMed ID: 32951893
[TBL] [Abstract] [Full Text] [Related]
17. Age-specific predictors of cervical dysplasia recurrence after primary conization: analysis of 3,212 women.
Bogani G; Pinelli C; Chiappa V; Martinelli F; Lopez S; Ditto A; Raspagliesi F
J Gynecol Oncol; 2020 Sep; 31(5):e60. PubMed ID: 32808492
[TBL] [Abstract] [Full Text] [Related]
18. Tip60 and p300 function antagonistically in the epigenetic regulation of HPV18 E6/E7 genes in cervical cancer HeLa cells.
Lai Y; He Z; Zhang A; Yan Z; Zhang X; Hu S; Wang N; He H
Genes Genomics; 2020 Jun; 42(6):691-698. PubMed ID: 32399935
[TBL] [Abstract] [Full Text] [Related]
19. Genome-wide somatic copy number alteration analysis and database construction for cervical cancer.
Luo H; Xu X; Yang J; Wang K; Wang C; Yang P; Cai H
Mol Genet Genomics; 2020 May; 295(3):765-773. PubMed ID: 31901979
[TBL] [Abstract] [Full Text] [Related]
20. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S; Yim S; Park H
Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
[TBL] [Abstract] [Full Text] [Related]
[Next]
